A detailed history of Manufacturers Life Insurance Company, The transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 69,230 shares of NUVB stock, worth $193,844. This represents 0.0% of its overall portfolio holdings.

Number of Shares
69,230
Previous 70,963 2.44%
Holding current value
$193,844
Previous $207,000 23.19%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$2.3 - $3.83 $3,985 - $6,637
-1,733 Reduced 2.44%
69,230 $159,000
Q2 2024

Aug 14, 2024

SELL
$2.58 - $3.69 $140,308 - $200,673
-54,383 Reduced 43.39%
70,963 $207,000
Q1 2024

May 14, 2024

BUY
$1.46 - $3.97 $82,736 - $224,975
56,669 Added 82.52%
125,346 $456,000
Q4 2023

Feb 13, 2024

SELL
$0.96 - $1.53 $30,397 - $48,445
-31,664 Reduced 31.56%
68,677 $103,000
Q3 2023

Nov 15, 2023

SELL
$1.26 - $2.1 $45 - $75
-36 Reduced 0.04%
100,341 $134,000
Q2 2023

Aug 11, 2023

BUY
$1.56 - $1.84 $26,967 - $31,808
17,287 Added 20.81%
100,377 $180,000
Q4 2022

Aug 11, 2023

BUY
$1.68 - $2.5 $10,303 - $15,332
6,133 Added 7.97%
83,090 $159,000
Q4 2022

Feb 13, 2023

BUY
$1.68 - $2.5 $10,303 - $15,332
6,133 Added 7.97%
83,090 $159,000
Q3 2022

Aug 11, 2023

BUY
$0.29 - $4.04 $9,167 - $127,712
31,612 Added 69.71%
76,957 $172,000
Q3 2022

Nov 03, 2022

BUY
$0.29 - $4.04 $9,167 - $127,712
31,612 Added 69.71%
76,957 $170,000
Q2 2022

Aug 11, 2023

SELL
$3.24 - $5.85 $51,341 - $92,699
-15,846 Reduced 25.9%
45,345 $146,000
Q2 2022

Aug 15, 2022

SELL
$3.24 - $5.85 $51,341 - $92,699
-15,846 Reduced 25.9%
45,345 $147,000
Q1 2022

Aug 11, 2023

SELL
$4.6 - $8.83 $100,735 - $193,368
-21,899 Reduced 26.36%
61,191 $321,000
Q1 2022

May 20, 2022

SELL
$4.6 - $8.83 $58,778 - $112,829
-12,778 Reduced 17.27%
61,191 $322,000
Q4 2021

Feb 16, 2022

BUY
$7.75 - $10.05 $303,629 - $393,738
39,178 Added 112.61%
73,969 $629,000
Q3 2021

Nov 12, 2021

BUY
$7.78 - $10.0 $115,945 - $149,030
14,903 Added 74.93%
34,791 $346,000
Q2 2021

Aug 12, 2021

BUY
$9.22 - $14.48 $183,367 - $287,978
19,888 New
19,888 $185,000

Others Institutions Holding NUVB

About Nuvation Bio Inc.


  • Ticker NUVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 217,244,000
  • Market Cap $608M
  • Description
  • Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...
More about NUVB
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.